IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

SARZI PUTTINI, PIERCARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 34.586
NA - Nord America 24.819
AS - Asia 18.832
SA - Sud America 5.469
AF - Africa 910
OC - Oceania 805
Continente sconosciuto - Info sul continente non disponibili 54
Totale 85.475
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.047
NL - Olanda 11.083
GB - Regno Unito 6.274
CN - Cina 5.377
IT - Italia 4.953
SG - Singapore 4.353
BR - Brasile 3.986
DE - Germania 2.145
HK - Hong Kong 1.978
RU - Federazione Russa 1.870
SE - Svezia 1.535
IN - India 1.469
TR - Turchia 1.331
FR - Francia 1.201
ES - Italia 1.134
IE - Irlanda 1.108
CA - Canada 961
AU - Australia 731
ID - Indonesia 636
MX - Messico 629
UA - Ucraina 567
VN - Vietnam 560
JP - Giappone 512
KR - Corea 490
CO - Colombia 467
PT - Portogallo 366
FI - Finlandia 350
CL - Cile 348
EG - Egitto 328
BE - Belgio 290
IL - Israele 284
PK - Pakistan 279
PL - Polonia 266
AR - Argentina 246
IQ - Iraq 242
CH - Svizzera 224
DK - Danimarca 205
TW - Taiwan 199
EU - Europa 183
AT - Austria 182
CI - Costa d'Avorio 182
NO - Norvegia 178
IR - Iran 149
SA - Arabia Saudita 149
EC - Ecuador 145
PE - Perù 135
GR - Grecia 132
ZA - Sudafrica 121
BD - Bangladesh 115
RO - Romania 101
TH - Thailandia 101
PH - Filippine 98
NZ - Nuova Zelanda 72
MY - Malesia 70
VE - Venezuela 63
UZ - Uzbekistan 57
SI - Slovenia 54
MA - Marocco 51
RS - Serbia 49
AE - Emirati Arabi Uniti 40
HU - Ungheria 40
BG - Bulgaria 39
CZ - Repubblica Ceca 38
HR - Croazia 37
JO - Giordania 37
PY - Paraguay 37
LB - Libano 34
LT - Lituania 32
KE - Kenya 31
CR - Costa Rica 30
TN - Tunisia 30
PA - Panama 29
AZ - Azerbaigian 25
BO - Bolivia 25
EE - Estonia 24
LY - Libia 24
DZ - Algeria 22
LK - Sri Lanka 22
NP - Nepal 20
QA - Qatar 20
SK - Slovacchia (Repubblica Slovacca) 20
BH - Bahrain 19
AP - ???statistics.table.value.countryCode.AP??? 18
KZ - Kazakistan 18
DO - Repubblica Dominicana 17
OM - Oman 17
CY - Cipro 16
PR - Porto Rico 16
PS - Palestinian Territory 16
AL - Albania 15
AM - Armenia 15
UY - Uruguay 15
IS - Islanda 14
NG - Nigeria 14
GH - Ghana 13
HN - Honduras 13
MD - Moldavia 13
NI - Nicaragua 13
SY - Repubblica araba siriana 13
JM - Giamaica 12
Totale 85.354
Salva come PNG Salva come JPEG
Città #
Southend 4.520
Singapore 2.536
Ashburn 1.992
Hong Kong 1.596
Fairfield 1.535
Chandler 1.497
Milan 1.198
Dublin 1.058
Beijing 1.048
Seattle 995
Princeton 969
Wilmington 886
Woodbridge 767
Dallas 724
Council Bluffs 717
Houston 648
Redwood City 641
Santa Clara 537
Los Angeles 521
Cambridge 511
Bengaluru 454
Ann Arbor 432
Boardman 423
São Paulo 396
Jakarta 382
Nanjing 382
Des Moines 381
Jacksonville 372
Hefei 356
Frankfurt am Main 351
Rome 350
Buffalo 325
Moscow 307
Istanbul 292
Toronto 270
Guangzhou 266
Hanover 255
Central District 230
Bogotá 227
Columbus 220
Dearborn 208
Phoenix 207
Tokyo 205
London 201
Chicago 196
Cangzhou 195
Santiago 183
Abidjan 181
Shanghai 181
Redmond 176
Ho Chi Minh City 175
The Dalles 175
Sydney 173
Munich 171
Ankara 170
Mountain View 167
New York 167
Melbourne 145
Jinan 143
Cairo 140
Shenyang 137
Madrid 134
Brisbane 132
Helsinki 125
Serra 125
Hanoi 124
Berlin 121
Heidelberg 118
Andover 117
Paris 117
Barcelona 115
Manchester 115
San Diego 113
Florence 109
Lisbon 109
Belo Horizonte 107
Nanchang 107
Warsaw 106
Mumbai 104
Rio de Janeiro 104
Taipei 103
Sakarya 102
Lahore 98
Stockholm 98
Brussels 94
Tianjin 90
Vienna 90
Baghdad 89
Changsha 89
Tel Aviv 89
Fuzhou 88
Porto Alegre 88
Naples 87
Seoul 85
Fortaleza 84
Ottawa 84
Brasília 82
Turin 81
Nuremberg 80
Lima 79
Totale 39.245
Salva come PNG Salva come JPEG
Nome #
Doctors' insights into the patient perspective : a qualitative study in the field of chronic pain 10.356
EULAR revised recommendations for the management of fibromyalgia 9.775
Biomarkers in Rheumatoid Arthritis 1.805
Pain and ketoprofen: what is its role in clinical practice? 1.368
Fibromyalgia: one year in review 2023 1.197
Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study 1.167
The Role of Hyperbaric Oxygen Therapy in Orthopedics and Rheumatological Diseases 898
EULAR evidence-based recommendations for the management of fibromyalgia syndrome 785
Symptoms and signs in fibromyalgia syndrome 763
AAPT Diagnostic Criteria for Fibromyalgia 735
The prevalence of fibromyalgia in the general population: A comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria 623
Cardiovascular involvement in psoriatic arthritis 599
Hypersomnolence in fibromyalgia syndrome 484
Psychiatric problems in fibromyalgia : clinical and neurobiological links between mood disorders and fibromyalgia 477
Fibromyalgia and arthritides 471
Fibromyalgia and the concept of resilience 465
Systemic rheumatic diseases : from biological agents to small molecules 426
Validation of the reflux disease questionnaire for an Italian population of patients with gastroesophageal reflux disease 418
Quality of life and unmet needs in patients with inflammatory arthropathies: Results from the multicentre, observational RAPSODIA study 417
Pain in systemic connective tissue diseases 386
Non pharmacological treatments in fibromyalgia 383
One year in review 2017 : fibromyalgia 367
Neuromuscular efficiency in fibromyalgia is improved by hyperbaric oxygen therapy : looking inside muscles by means of surface electromyography 357
Patient-reported impact of spondyloarthritis on work disability and working life : The ATLANTIS survey 334
Paradoxical expansion of Th1 and Th17 lymphocytes in rheumatoid arthritis following infliximab treatment: a possible explanation for a lack of clinical response 320
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 317
Inflammatory response and the endothelium 315
Fibromyalgia syndrome : preventive, social and economic aspects 304
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group 302
Prédicteurs de la réponse aux traitements anti-TNF chez les patients ayant une polyarthrite rhumatoïde avec des scores DAS28 modérés ou élevés 300
Artrite reumatoide all’esordio = Early rheumatoid arthritis 294
The evaluation of the fibromyalgia patients 279
Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment 265
Psychometric characteristics of the Italian version of the revised Fibromyalgia Impact Questionnaire using classical test theory and Rasch analysis 255
Preliminary identification of key clinical domains for outcome evaluation in fibromyalgia using the Delphi method : the Italian experience 253
Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I) 252
Infections and Biological Therapy in Patients with Rheumatic Diseases 250
Serum klotho concentrations inversely correlate with the severity of nailfold capillaroscopic patterns in patients with systemic sclerosis 250
Reliability and diagnostic accuracy of radiography for the diagnosis of calcium pyrophosphate deposition: performance of the novel definitions developed by an international multidisciplinary working group 234
Impact of Moving From a Widespread to Multisite Pain Definition on Other Fibromyalgia Symptoms 229
Hepatotropic viruses : new insights in pathogenesis and treatment 226
Infliximab-induced lupus in Crohn's disease: a case report 218
CD69 expression on neutrophils from patients with rheumatoid arthritis 217
Correlation of the score for subjective pain with physical disability, clinical and radiographic scores in recent onset rheumatoid arthritis 217
Chronic widespread pain in spondyloarthritis 216
Neurophysiological background for physical therapies in fibromyalgia 211
A proteinuria cut-off level of 0.7 g /day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: Data from the MAINTAIN Nephritis Trial 210
Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia 207
One year in review 2016 : fibromyalgia 205
Significance of serum Il-9 levels in inflammatory bowel disease 202
New parameters for identifying subclinical atherosclerosis in patients with primary Sjögren's syndrome : a pilot study 201
Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age 201
Palmitoylethanolamide and acetyl-L-carnitine act synergistically with duloxetine and pregabalin in fibromyalgia: results of a randomised controlled study 200
Cyclic alternating pattern (CAP) : a new marker of sleep alteration in patients with fibromyalgia? 200
Measurement of Serum Klotho in Systemic Sclerosis 200
The immunogenicity of branded and biosimilar infliximab in rheumatoid arthritis according to Th9-related responses 200
Developing new classification criteria for diffuse idiopathic skeletal hyperostosis : back to square one 200
B Lymphocyte intestinal homing in inflammatory bowel disease 199
Brain Modulation by Electric Currents in Fibromyalgia: A Structured Review on Non-invasive Approach With Transcranial Electrical Stimulation 198
Visceral hypersensitivity is not a feature of fibromyalgia syndrome 195
Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study 195
Primary and secondary autoimmune neutropenia 194
Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A : a case report 193
Pain in rheumatoid arthritis : a critical review 192
Can speckle tracking echocardiography detect subclinical left ventricular dysfunction in patients with primary Sjögren's syndrome? 192
The role of klotho in systemic sclerosis 191
From endothelial dysfunction to atherosclerosis 190
Usefulness of six-minute walk test in systemic sclerosis 190
Silent cardiovascular involvment in patients with diffuse scleroderma : a controlled cross-sectional study 188
Extraintestinal manifestations of inflammatory bowel disease 186
Highlights on novel technologies for the detection of antibodies to Ro60, Ro52, and SS-B 186
RS3PE and the role of ultrasound. A case report and brief review of the literature 185
HIV/AIDS : epidemic update, new treatment strategies and impact on autoimmunity 184
Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib 184
La medicina complementare nell'artrite reumatoide = Complementary medicine in rheumatoid arthritis 184
Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain 181
Is fibromyalgia an autoimmune disorder? 180
The heart in rheumatoid arthritis 179
Combined therapeutic approach : Inflammatory bowel diseases and peripheral or axial arthritis 179
Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate 177
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series 177
Tumour necrosis factor α is expressed in refractory skin lesions from patients with subacute cutaneous lupus erythematosus 176
Definition of fibromyalgia severity: findings from a cross-sectional survey of 2339 Italian patients 175
Clinical, Ultrasound, and Predictability Outcomes Following Certolizumab Pegol Treatment (with Methotrexate) in Patients with Moderate-to-Severe Rheumatoid Arthritis : 52-Week Results from the CZP-SPEED Study 173
Tumor necrosis factor-alpha, biologic agents and cardiovascular risk. 172
Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools 172
Evaluation of salivary and plasma microRNA expression in patients with Sjögren's syndrome, and correlations with clinical and ultrasonographic outcomes 172
Inflammatory bowel disease versus irritable bowel syndrome : a hospital-based, case-control study of disease impact on quality of life 171
Anti-tumour necrosis factor-α antibodies and B cell homeostasis in human inflammatory bowel diseases 171
Etiopathogenetic mechanisms of fibromyalgia syndrome 170
Autonomic abnormalities in patients with primary Sjogren’s syndrome – Preliminary results 170
Autoantibody profile during short-term infliximab treatment for Crohn's disease : a prospective cohort study 168
Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control : The State-of-The-Art 168
Drug-induced lupus erythematosus 167
Possible relationship between certolizumab pegol and arrhythmias : Report of two cases 167
Is it antiphospholipid syndrome? 166
The Italian version of the Fibrofatigue Scale, a reliable tool for the evaluation of fibromyalgia symptoms 165
Reactivation of occult hepatitis B virus infection under treatment with abatacept : a case report 165
Thyroid acropachy: An unusual rheumatic manifestation of Graves' disease 164
Barriers to pain management : focus on opioid therapy 161
Totale 50.718
Salva come PNG Salva come JPEG
Categoria #
all - tutte 220.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.419
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.454 0 0 0 0 711 875 547 559 850 517 839 556
2021/20227.006 507 434 562 425 554 408 474 538 733 717 514 1.140
2022/20238.474 1.055 577 560 745 855 1.449 383 569 1.002 332 530 417
2023/20248.089 357 630 525 621 1.176 809 525 584 375 557 892 1.038
2024/202518.616 845 1.829 889 1.793 1.291 1.014 852 1.786 1.355 1.607 2.311 3.044
2025/202611.688 2.917 2.059 2.968 2.642 1.102 0 0 0 0 0 0 0
Totale 88.816